The Knock Out Cancer Act directs the National Cancer Institute to receive a significant funding increase for cancer research between fiscal years 2024 and 2028, adding 25 percent of its 2022 budget annually to address what supporters argue is insufficient research funding relative to cancer's mortality burden. This additional funding, which will be appropriated from the general Treasury, is meant to supplement rather than replace the institute's regular budget allocations. The bill also requires the Secretary of Health and Human Services, working with the Food and Drug Administration and other relevant agencies, to complete a comprehensive study within one year examining the causes of cancer drug shortages, including economic factors, supply chain problems, development delays, FDA approval complications, and gaps in generic and biosimilar drug availability. The bill directs the Secretary to include recommendations in the resulting report for how to address these shortages and submit the findings to Congress, aimed at improving access to cancer treatments for patients.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.